RxDoctor Payments Data

Kelsie Tescher

Physician Assistant · Bismarck, NDNPI 1184115685

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,555in general payments, 2019–2025

Across 168 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$547
  • Amgen$320
  • Lilly USA, LLC$263
  • Novo Nordisk$257
  • Pfizer$230
  • Boehringer Ingelheim$134
  • plus $804 from 16 others

What the payments were for

  • Food & beverage$2,555100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,555 in reported general payments places this provider in the 90th percentile of 355 physician assistant providers in North Dakota.

See all physician assistant providers in North Dakota

Medicare billing

Part B allowed, 2024
$15,139
Medicare patients
117
Services billed
283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$34,406
MounjaroTirzepatide26$29,799
Gabapentin113$949
Pregabalin46$816
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$482
Atorvastatin Calcium47$480
Levothyroxine Sodium32$441
Metformin Hcl26$349
Omeprazole22$342
Rosuvastatin Calcium23$339
Fluticasone Propionate16$299
Tizanidine Hcl28$288
Allopurinol14$273
Losartan Potassium30$262
Pantoprazole Sodium31$253

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$230$34,40628 claims
Lilly USA, LLCMounjaro$263$29,79926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 355 physician assistant providers in North Dakota.

Other physician assistant in Bismarck

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →